Delivery Order SPE2DB25D9320-SPE2DB25FWEYM

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,464.30 contract is for the delivery of Armour Thyroid 90 mg tablets. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,259.88, is for the delivery of Armour Thyroid 120 mg tablets in 100-count packages. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products, including...
This federal contract award is a delivery order under a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, issued under the DLA's SPE2DB program, allows the DLA to place firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, from common medications...
This is a firm fixed-price delivery order valued at $1,339.00 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,556,231,977 units of Armour Thyroid 30 mg tablets. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,259.88 firm fixed-price delivery order is for the provision of Armour Thyroid 120 mg tablets, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,374.48 firm fixed-price delivery order is for the supply of Armour Thyroid 60 mg tablets in 100-count bottles. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of Armour Thyroid 120 mg tablets for a period ending on January 29, 2025, with a ceiling value of $1,049.90. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This federal contract award, with ID SPE2DB20D6037|SPE2DB23FC9VR, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Armour Thyroid 60 mg tablets, with a ceiling value of $6,089.25 and an ultimate completion date of December 8, 2022. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,234.41, is for the supply of 4,566,795,517 units of 15 mg Armour Thyroid tablets. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,075.43 issued under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical supply program. The award, which has a completion date of May 22, 2024, is for the supply of Armour Thyroid 60 mg tablets. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a wide range of pharmaceutical products...
  • SPE2DB25D9320
    Indefinite Delivery Contract
  • SPE2DB25D9320-SPE2DB25FWEYM
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,259.88 contract is for the delivery of Armour Thyroid 120 mg tablets to support the medical supply needs of military healthcare facilities.

The award is part of DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/12/25, 10:40 AM